Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...
| Autors principals: | , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Greater Baltimore Medical Center
2018-09-01
|
| Col·lecció: | Journal of Community Hospital Internal Medicine Perspectives |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/20009666.2018.1527667 |